NuCana plc (NCNA)
NASDAQ: NCNA · Real-Time Price · USD
2.330
+0.060 (2.64%)
At close: May 29, 2026, 4:00 PM EDT
2.290
-0.040 (-1.72%)
After-hours: May 29, 2026, 7:52 PM EDT
NuCana Employees
As of December 31, 2025, NuCana had 12 total employees, including 10 full-time and 2 part-time employees. The number of employees decreased by 10 or -45.45% compared to the previous year.
Employees
12
Change (1Y)
-10
Growth (1Y)
-45.45%
Revenue / Employee
n/a
Profits / Employee
-$3,383,159
Market Cap
9.70M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 12 | -10 | -45.45% | 10 | 2 |
| Dec 31, 2024 | 22 | -6 | -21.43% | 20 | 2 |
| Dec 31, 2023 | 28 | -3 | -9.68% | 25 | 3 |
| Dec 31, 2022 | 31 | -2 | -6.06% | 28 | 3 |
| Dec 31, 2021 | 33 | 4 | 13.79% | 31 | 2 |
| Jun 30, 2021 | 28 | - | - | 28 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bolt Biotherapeutics | 23 |
| BioCardia | 21 |
| Imunon | 20 |
| Soligenix | 14 |
| BioVie | 13 |
| Aprea Therapeutics | 8 |
| Immuron | 7 |
| Quoin Pharmaceuticals | 6 |
NCNA News
- 15 days ago - NuCana Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - NuCana appoints Bruce as COO - TheFly
- 5 months ago - NuCana Appoints Theresa Bruce as Chief Operating Officer - GlobeNewsWire
- 6 months ago - NuCana presents latest clinical data at ESMO 2025 on NUC-7738 - TheFly
- 6 months ago - NuCana presents data at ESMO on NUC-7738 - TheFly
- 6 months ago - NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma - GlobeNewsWire
- 7 months ago - NuCana Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire